The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...

The CSU indication is the seventh disease driven in part by underlying type 2 inflammation in which Dupixent has received approval.

Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...

Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives ...

As temperatures rise and outdoor activities increase, Clark County officials are warning residents of pissbleAccording to the ...

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announces the publication of ...

Two cases of alpha-gal syndrome suggest that the lone star tick isn’t the only species in the United States capable of triggering an allergy to red meat.

A woman with a rare allergy to cold temperatures has revealed how even a few minutes outside in chilly weather can leave her ...

The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and ...

Urticaria, commonly known as hives, is a skin condition that manifests as itchy welts or raised patches on the skin. These welts can vary in size and often change shape or location, making the ...

Other skin reactions are possible depending on the medication you're taking. Maculopapular (also called morbilliform) rash More common Small, flat or raised areas with pink-red spots (on lighter skin) ...